Literature DB >> 29132976

Investigations into the carbonic anhydrase inhibition of COS-releasing donor core motifs.

Andrea K Steiger1, Yu Zhao1, Won Jin Choi1, Alder Crammond1, McKinna R Tillotson1, Michael D Pluth2.   

Abstract

Carbonyl sulfide (COS) releasing scaffolds are gaining popularity as hydrogen sulfide (H2S) donors through exploitation of the carbonic anhydrase (CA)-mediated hydrolysis of COS to H2S. The majority of compounds in this emerging class of donors undergo triggerable decomposition (often referred to as self-immolation) to release COS, and a handful of different COS-releasing structures have been reported. One benefit of this donation strategy is that numerous caged COS-containing core motifs are possible and are poised for development into self-immolative COS/H2S donors. Because the intermediate release of COS en route to H2S donation requires CA, it is important that the COS donor motifs do not inhibit CA directly. In this work, we investigate the cytotoxicity and CA inhibition properties of different caged COS donor cores, as well as caged CO2 and CS2 motifs and non-self-immolative control compounds. None of the compounds investigated exhibited significant cytotoxicity or enhanced cell proliferation at concentrations up to 100 μM in A549 cells, but we identified four core structures that function as CA inhibitors, thus providing a roadmap for the future development of self-immolative COS/H2S donor motifs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbonic anhydrase; Carbonyl sulfide; Hydrogen sulfide

Mesh:

Substances:

Year:  2017        PMID: 29132976      PMCID: PMC5866179          DOI: 10.1016/j.bcp.2017.11.004

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  32 in total

1.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

2.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

Authors:  Rui Wang
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

3.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

Review 4.  Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues.

Authors:  Yueqin Zheng; Bingchen Yu; Ladie Kimberly De La Cruz; Manjusha Roy Choudhury; Abiodun Anifowose; Binghe Wang
Journal:  Med Res Rev       Date:  2017-02-27       Impact factor: 12.944

5.  Lanthanum(III) isopropoxide catalyzed chemoselective transesterification of dimethyl carbonate and methyl carbamates.

Authors:  Manabu Hatano; Sho Kamiya; Katsuhiko Moriyama; Kazuaki Ishihara
Journal:  Org Lett       Date:  2010-12-22       Impact factor: 6.005

Review 6.  Hydrogen sulfide is a signaling molecule and a cytoprotectant.

Authors:  Hideo Kimura; Norihiro Shibuya; Yuka Kimura
Journal:  Antioxid Redox Signal       Date:  2012-03-02       Impact factor: 8.401

Review 7.  The therapeutic potential of hydrogen sulfide: separating hype from hope.

Authors:  Kenneth R Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-04       Impact factor: 3.619

8.  Evaluation of ethyl N-(2-phenethyl) carbamate analogues as biofilm inhibitors of methicillin resistant Staphylococcus aureus.

Authors:  Matthew D Stephens; Nisakorn Yodsanit; Christian Melander
Journal:  Org Biomol Chem       Date:  2016-07-12       Impact factor: 3.876

9.  Therapeutic Delivery of H2S via COS: Small Molecule and Polymeric Donors with Benign Byproducts.

Authors:  Chadwick R Powell; Jeffrey C Foster; Benjamin Okyere; Michelle H Theus; John B Matson
Journal:  J Am Chem Soc       Date:  2016-10-07       Impact factor: 15.419

10.  Self-Immolative Thiocarbamates Provide Access to Triggered H2S Donors and Analyte Replacement Fluorescent Probes.

Authors:  Andrea K Steiger; Sibile Pardue; Christopher G Kevil; Michael D Pluth
Journal:  J Am Chem Soc       Date:  2016-06-03       Impact factor: 15.419

View more
  1 in total

1.  Cysteine-activated hydrogen sulfide (H2S) delivery through caged carbonyl sulfide (COS) donor motifs.

Authors:  Yu Zhao; Andrea K Steiger; Michael D Pluth
Journal:  Chem Commun (Camb)       Date:  2018-05-10       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.